Skip to content
COO Cooper Cos Inc-The NYSE
349.14 USD -0.19% -0.65
OPEN 349.71
DAY RANGE 349.72 - 348.19
52 WEEK RANGE 395.20 - 244.22
Interactive Brokers Logotype

Buy COO stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 17.3B
Enterprise value 17.4B
Trailing pe 60.10309
Forward pe 24.410328
Peg ratio 24.410328
Price to sales ttm 5.23451318583
Price to book mrq 2.4036777
Enterprise to revenue 5.2604994607665
Enterprise to ebitda 24.440157865468


Fiscal year ends 2022-10-31
Most recent quarter 2023-04-30
Profit margin 0.64671744649982
Operating margin 0.16098416152823
Return on assets ttm 0.033570303594581
Return on equity ttm 0.063003184453336
Income statement
Revenue ttm 3.3B
Revenue per share ttm 67.108
Quarterly revenue growth 0.02201514269074
Gross profit ttm 2.2B
Ebitda 648.6M
Net income to common ttm 385.8M
Diluted eps ttm 5.82
Quarterly earnings growth yoy 0.057363220053025
Balance sheet
Total debt mrq 2.6B
Total debt to equity mrq 0.4197856711292
Current ratio mrq 1.9551344743276
Book value per share mrq 145.527
Cash flow
Operating cash flow ttm 682.9M
Levered free cash flow ttm 1.2B

Stock statistics

Shares outstanding 49.5M
Avg 10 volume 469.8K
Avg 30 volume 331.4K
Shares short 1.2M
Short ratio 5.77
Short percent of shares outstanding 0.0273
Percent held by insiders 0.0055400003
Percent held by institutions 1.01165

Stock price summary

Fifty two week low 244.22
Fifty two week high 395.2
Fifty two week change 4.925
Day 50 ma 376.4724
Day 200 ma 328.80536

Dividends and splits

Forward annual dividend rate 0.06
Forward annual dividend yield 0.0002
Trailing annual dividend rate 0.06
Trailing annual dividend yield 0.00017185083347654
5 year average dividend yield 0.02
Payout ratio 0.010299999
Dividend date 2023-02-10
Ex dividend date 2023-01-20
Last split factor 2-for-1 split
Last split date 2002-11-25

The Cooper Companies (COO) company profile

The Cooper Companies Inc. (NYSE: COO) is a medical device company that engages in the production of contact lens wearers. The company operates through the segments of CooperVision and CooperSurgical. Its products are primarily designed to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric, and multifocal contact lenses.